Skip to Content

BAYER 40 (Stivarga 40 mg)

Generic Name: regorafenib

Pill with imprint BAYER 40 is Pink, Elliptical / Oval and has been identified as Stivarga 40 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc..

Stivarga is used in the treatment of hepatocellular carcinoma; gastrointestinal stromal tumor; colorectal cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Stivarga 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BAYER 40

Stivarga 40 mg BAYER 40

Stivarga

Generic Name
regorafenib
Imprint
BAYER 40
Strength
40 mg
Color
Pink
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bayer HealthCare Pharmaceuticals Inc.
National Drug Code (NDC)
50419-0171
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, silicon dioxide, ferric oxide red, ferric oxide yellow, soya lecithin, polyethylene glycol 3350, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "BAYER 40"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.